From the moment the calendar flips from October to November, bellies across the country start to rumble. With Thanksgiving at the end of the month, who can help but to think about the wonderful meal which awaits? Whether it be anxiously preparing for the indulgence of the holiday season or…...
Targeted Lung Cancer Therapy
A Match Made Possible A discovery by a team led by Massachusetts General Hospital’s Daniel Haber, M.D., Ph.D., a physician-scientist supported by the National Foundation for Cancer Research since 2003, now represents a source of hope for many patients with metastatic lung cancer. He and his colleagues correctly linked very…...
New Type of Lung Cancer Identified
A research team at Cold Spring Harbor Laboratory discovered a new kind of small-cell lung cancer (SCLC). While the general public may not consider this particularly good news, the identification paves the way for developing more specific and personalized medicine approaches to target this previously unnoticed form of the disease....
Global Coalition for Adaptive Research (GCAR) Names Gary Gordon Interim Chief Executive Officer
FOR IMMEDIATE RELEASE: November 8, 2018 CONTACT: Global Coalition for Adaptive Research Rachel Rosenstein-Sisson, Executive Assistant E-mail: rrosenstein.sisson@gcaresearch.org / Phone: 617-299-6471 National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 LEXINGTON, MA & ROCKVILLE, MD – Gary Gordon, M.D., Ph.D.,…...
National Family Caregivers Month
Nearly every month is dedicated to shining awareness on particular diseases. It is an incredible way to educate those unfamiliar with an illness, as well as to assist those affected in finding support systems. These awareness months also extend beyond medical conditions, including special categories of people. Altogether, these designations…...
November Is Pancreatic Cancer Awareness Month
Even in the company of other vicious diseases, pancreatic cancer is particularly nasty: The one-year relative survival rate is 20% and the five-year rate is 7%. It ranks third in cancer-related deaths in the United States, and it is expected that over 55,000 Americans will be diagnosed this year alone.…...
Strategic Media Partner
